Showing results (231-240 of 398) with videos related to
Sort By:
Pageof 40
The Bone & Joint Journal|March 30, 2013
Extended venous thromboembolism prophylaxis in patients undergoing hip fracture surgery - the SAVE-HIP3 studyW D Fisher, G Agnelli, D J George, et al.Thrombosis and Haemostasis|August 1, 1995
Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosisM N Levine, J Hirsh, M Gent, et al.Journal of Thrombosis and Haemostasis : JTH|October 26, 2005
BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging studyA G G Turpie, W D Fisher, K A Bauer, et al.Journal of Thrombosis and Haemostasis : JTH|August 1, 2007
A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgeryB I Eriksson, A G G Turpie, M R Lassen, et al.The Journal of Bone and Joint Surgery. British Volume|May 2, 2009
Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacementB I Eriksson, A K Kakkar, A G G Turpie, et al.Journal of Thrombosis and Haemostasis : JTH|August 21, 2010
Thromboxane Antagonism with terutroban in Peripheral Arterial Disease: the TAIPAD studyJ N Fiessinger, H Bounameaux, M A Cairols, et al.Current Medical Research and Opinion|July 6, 2017
A post-marketing assessment of major bleeding in total hip and total knee replacement surgery patients receiving rivaroxabanLouis M Kwong, Alexander G G Turpie, Sally Tamayo, et al.TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Patient Management Strategies and Long-Term Outcomes in Isolated Distal Deep-Vein Thrombosis versus Proximal Deep-Vein Thrombosis: Findings from XALIAWalter Ageno, Lorenzo G Mantovani, Sylvia Haas, et al.Clinical Cardiology|July 1, 2016
Impact of Switching From a Vitamin K Antagonist to Rivaroxaban on Satisfaction With Anticoagulation Therapy: The XANTUS-ACTS SubstudyCraig I Coleman, Sylvia Haas, Alexander G G Turpie, et al.The New England Journal of Medicine|June 27, 2008
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplastyMichael R Lassen, Walter Ageno, Lars C Borris, et al.Pageof 40